Patent US5179005A successfully refreshed from Google Patents.
US5179005A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Minimum procedure system for the determination of analytes
Assignee: LifeScan Inc
•
Filing: 1988-04-28
•
Granted: 1993-01-12
•
Expires: 2008-04-28
Abstract
Abstract A method for determining the presence of an analyte in a fluid is described along with various components of an apparatus specifically designed to carry out the method. The method involves taking a reflectance reading from one surface of an inert porous matrix impregnated with a reagent that will interact with the analyte to produce a light-absorbing reaction product when the fluid being analyzed is applied to another surface and migrates through the matrix to the surface being read. Reflectance measurements are made at two separate wavelengths in order to eliminate interferences, and a timing circuit is triggered by an initial decrease in reflectance by the wetting of the surface whose reflectance is being measured by the fluid which passes through the inert matrix. Repeatability is insured by a normalization technique performed on the light source before each reading, and an alignment method operated on the reagent strip prior to emplacement on the apparatus. The method and apparatus are particularly suitable for the measurement of glucose levels in blood without requiring separation of red blood cells from serum or plasma.
Inventors
- 👤 Roger Phillips
- 👤 Geoffery McGarraugh
- 👤 Franklin A. Jurik
- 👤 Raymond D. Underwood
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:33
CPC Classifications
G; G01; G01N; G01N21/00; G01N21/84; G01N21/8483; G01N33/00; C; C12; C12Q; C12Q1/00; C12Q1/54; G01N33/48; G01N33/50; G01N33/52; G01N33/521; G01N33/523; G01N33/66; G01N21/17; G01N21/47; G01N21/4738; G01N21/474; G01N2021/4752; G01N2021/4757; G01N21/25; G01N21/31; G01N21/314; G01N35/00; G01N35/10; G01N35/1009; G01N35/1016; Y; Y02; Y02A; Y02A90/00; Y02A90/10; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S435/808; Y10S435/81; Y10T; Y10T436/00; Y10T436/11; Y10T436/112499; Y10T436/14; Y10T436/142222; Y10T436/143333; Y10T436/144444
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
186 words
A method for determining glucose in a blood sample employing a membrane and a signal-producing system which reacts with glucose to produce a light-absorptive dye product, said system being bound to the membrane, and in which the amount of said dye product is determined by means of a reflectance measurement from a surface of said membrane, an improvement which comprises: applying an unmeasured whole blood sample to a first porous, hydrophilic membrane having pores of a size sufficient to exclude red blood cells and which contains said signal-producing system; placing said matrix in a reflectance scanning meter wherein said meter detects the presence of said blood sample on said matrix, said reflectance scanning meter initiating a timing sequence upon detecting the presence of said blood sample in matrix; taking reflectance measurements: (1) from the background within said meter (R b ); (2) before said matrix contains blood (R dry ); and (3) at a predetermined time (R t ), then computing R*t wherein R*t=(R.sub.t -R.sub.b)/(R.sub.dry -R.sub.b); using R*t to compute K/S-t, wherein K/S-t is defined as (1-R*t).sup.2 /(2×R*t); and computing glucose levels from said K/S-t value.
Claim 2
Independent Claim
186 words
A method for determining glucose in a blood sample employing a membrane and a signal-producing system which reacts with glucose to produce a light-absorptive dye product, said system being bound to the membrane, and in which the amount of said dye product is determined by means of a reflectance measurement from a surface of said membrane, an improvement which comprises: applying an unmeasured whole blood sample to a first porous, hydrophilic membrane having pores of a size sufficient to exclude red blood cells and which contains said signal-producing system; placing said matrix in a reflectance scanning meter wherein said meter detects the presence of said blood sample on said matrix, said reflectance scanning meter initiating a timing sequence upon detecting the presence of said blood sample in matrix; taking reflectance measurements: (1) from the background within said meter (R b ); (2) before said matrix contains blood (R dry ); and (3) at a predetermined time (R t ), then computing R*t wherein R*t=(R.sub.t -R.sub.b)/(R.sub.dry -R.sub.b); using R*t to compute K/S-t, wherein K/S-t is defined as (1-R*t).sup.2 /(2×R*t); and computing glucose levels from said K/S-t value.
Claim 3
Dependent Claim
21 words
The method of claim 1 wherein said predetermined time is 20 seconds and said glucose level is defined as: -55.75+0.1632×(K/S-t)-(5.765×10.sup.-5)×(K/S-t).sup.2 +(2.58×10.sup.-8)×(K/S-t).sup.3.
Claim 4
Dependent Claim
23 words
The method of claim 1 wherein said predetermined endpoint in time is 30 seconds and said glucose level is defined as: -55.25+0.1334×(K/S-t)-(2.241×10.sup.-5)×(K/S-t).sup.2 +(1.20×10.sup.-8)×(K/S-t).sup.3.
Claim 5
Independent Claim
248 words
A method for determining glucose in a blood sample employing a membrane and a signal-producing system which reacts with glucose to produce a light-absorptive dye product, said system being bound to the membrane, and in which the amount of said dye product is determined by means of a reflectance measurement from a surface of said membrane, an improvement which comprises: applying an unmeasured whole blood sample to a first porous, hydrophilic membrane having pores of a size sufficient to exclude red blood cells and which contains said signal-producing system; placing said matrix in a reflectance scanning meter, wherein said meter detects the presence of said blood sample on said matrix, said reflectance scanning meter initiating a timing sequence upon detecting the presence of said blood sample in said matrix; taking reflectance measurements: (1) from the background within said meter (R b ); (2) before said matrix contains blood (R dry ); (3) at 15 seconds after said matrix contains blood (R 15 ); and (4) at a predetermined endpoint (R t ); using said readings to compute R*15 and R*t according to the following properties: R*15=(R.sub.15 -R.sub.b)/(R.sub.dry -R.sub.b) R*t=(R.sub.t -R.sub.b)/(R.sub.dry -R.sub.b); computing K/S 15 and K/S t levels where said levels are defined as: K/S.sub.15 =(1-R*15).sup.2 /(2×R*15) K/S.sub.t =(1-R*t).sup.2 /(2×R*t); normalizing said K/S 15 value to arrive at a K/S 15n value defined as K/S.sub.15n =(1.54×K/S.sub.15)-0.1333; arriving at a K/S t/15 value defined as K/S.sub.t/15 =K/S.sub.t -/S.sub.15n ; and using said K/S t/15 value to compute glucose levels.
Claim 6
Independent Claim
248 words
A method for determining glucose in a blood sample employing a membrane and a signal-producing system which reacts with glucose to produce a light-absorptive dye product, said system being bound to the membrane, and in which the amount of said dye product is determined by means of a reflectance measurement from a surface of said membrane, an improvement which comprises: applying an unmeasured whole blood sample to a first porous, hydrophilic membrane having pores of a size sufficient to exclude red blood cells and which contains said signal-producing system; placing said matrix in a reflectance scanning meter, wherein said meter detects the presence of said blood sample on said matrix, said reflectance scanning meter initiating a timing sequence upon detecting the presence of said blood sample in said matrix; taking reflectance measurements: (1) from the background within said meter (R b ); (2) before said matrix contains blood (R dry ); (3) at 15 seconds after said matrix contains blood (R 15 ); and (4) at a predetermined endpoint (R t ); using said readings to compute R*15 and R*t according to the following properties: R*15=(R.sub.15 -R.sub.b)/(R.sub.dry -R.sub.b) R*t=(R.sub.t -R.sub.b)/(R.sub.dry -R.sub.b); computing K/S 15 and K/S t levels where said levels are defined as: K/S.sub.15 =(1-R*15).sup.2 /(2×R*15) K/S.sub.t =(1-R*t).sup.2 /(2×R*t); normalizing said K/S 15 value to arrive at a K/S 15n value defined as K/S.sub.15n =(1.54×K/S.sub.15)-0.1333; arriving at a K/S t/15 value defined as K/S.sub.t/15 =K/S.sub.t -/S.sub.15n ; and using said K/S t/15 value to compute glucose levels.
Claim 7
Dependent Claim
21 words
The method of claim 4 wherein said predetermined end point is 20 seconds and said glucose level is defined as: ##EQU1##
Claim 8
Dependent Claim
21 words
The method of claim 4 wherein said predetermined end point is 30 seconds and said glucose level is defined as: ##EQU2##
References Cited (Backward Citations)
US3127281A
Cited
US2893843A
Cited
US3061523A
Cited
US3099605A
Cited
US2893844A
Cited
US3092465A
Cited
US3443903A
Cited
US3298789A
Cited
US3630957A
Cited
US3552928A
Cited
US3607093A
Cited
US3506126A
Cited
US3591480A
Cited
US3811840A
Cited
US3660638A
Cited
US3650698A
Cited
US3703336A
Cited
US3718439A
Cited
US3672838A
Cited
US3785772A
Cited
US4056468A
Cited
US3958560A
Cited
US3990849A
Cited
US3979274A
Cited
US4057394A
Cited
US4178153A
Cited
US4297238A
Cited
US4211845A
Cited
US4258001A
Cited
US4288228A
Cited
US4238196A
Cited
US4340669A
Cited
US4509859A
Cited
US4427632A
Cited
US4476222A
Cited
EP0141648A2
Cited
US4627445A
Cited
US4637403A
Cited
US4787398A
Cited
US4935346A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-01-12 | 1996-07-13 | 1997-01-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-01-12 | 2000-07-13 | 2001-01-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-01-12 | 2004-07-13 | 2005-01-12 | $7700.00 | Window Closed / Lapsed |